Pre-clinical studies on novel lipid therapeutics with anti-virulence and antibiotic synergising potential against Pseudomonas aeruginosa isolates from bronchiectatic airways
Chronic infections of the airways remain the leading cause of mortality in cystic fibrosis. Antibiotic therapy has drastically improved survival in this patient cohort, however, this therapy seldom, if ever, results in bacteriologic eradication of the infecting organism and acts only to suppress inf...
| Main Author: | |
|---|---|
| Published: |
University of Strathclyde
2016
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.742042 |